GOODRX, INC.

Lobbying for GOODRX, INC.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $300,000.00 expenses · posted Jan 20, 2026

Lobbying activity 2

Consumer Issues/Safety/Products

Monitoring federal legislation and outreach to congressional offices.

Health Issues

-Issues regarding prescription drug pricing. -Issues regarding telehealth.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.